Opgen Inc

0.00 (-0.25%)

Opgen's Ares Genetics Launches NGS-Based Antibiotic Resistance Testing Service For Native Specimens

Published: 11/12/2020 12:40 GMT
OpGen Inc (OPGN) - Opgen Inc - Ares Genetics Commercially Launches Ngs-based Antibiotic Resistance Testing Service for Native Specimens.
Opgen Inc - Ares Genetics Receives Bulk Order From Public Health Agency.
Opgen Inc - Ares Genetics Has Received Commercial Orders for Hundreds of Novel Aresupa Tests, Exceeding a Bulk Order Volume of Us$ 250,000.